KSE - Delayed Quote KRW

Jeil Pharmaceutical Co.,Ltd (271980.KS)

16,410.00 -10.00 (-0.06%)
At close: April 26 at 3:30 PM GMT+9

Key Executives

Jeil Pharmaceutical Co.,Ltd

343, Sapyeong-daero
Seocho-gu
Seoul, 06543
South Korea
82 2 549 7451 https://www.jeilpharm.co.kr
Sector: 
Healthcare

Description

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.

Corporate Governance

Jeil Pharmaceutical Co.,Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Dec 27, 2023
    Ex-Dividend Date

Upcoming Events

Related Tickers